Frederico Costa

5.2k total citations · 2 hit papers
72 papers, 3.0k citations indexed

About

Frederico Costa is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Frederico Costa has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 38 papers in Epidemiology and 23 papers in Neurology. Recurrent topics in Frederico Costa's work include Neuroendocrine Tumor Research Advances (35 papers), Lung Cancer Research Studies (28 papers) and Neuroblastoma Research and Treatments (23 papers). Frederico Costa is often cited by papers focused on Neuroendocrine Tumor Research Advances (35 papers), Lung Cancer Research Studies (28 papers) and Neuroblastoma Research and Treatments (23 papers). Frederico Costa collaborates with scholars based in Brazil, United States and France. Frederico Costa's co-authors include Ulrich‐Frank Pape, Ramón Salazar, Dermot O’Toole, Kjell Öberg, E. P. Krenning, Ulrich Knigge, Réza Kianmanesh, Danae C. Gross, Marianne Pavel and Jaume Capdevila and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Frederico Costa

69 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

2016 738 citations Marianne Pavel, Dermot O’Toole et al. Neuroendocrinology profile →
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum

2016 315 citations Frederico Costa, Danae C. Gross et al. Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederico Costa Brazil	23	2.0k	2.0k	1.4k	479	195	72	3.0k
Danae C. Gross United States	11	1.1k 0.6×	992 0.5×	753 0.6×	200 0.4×	226 1.2×	29	1.7k
Penelope Brock United Kingdom	34	692 0.3×	1.6k 0.8×	1.2k 0.9×	1.1k 2.3×	1.4k 7.0×	93	4.9k
G Bussolati Italy	28	737 0.4×	949 0.5×	417 0.3×	700 1.5×	543 2.8×	94	3.0k
M. Bamberg Germany	34	465 0.2×	746 0.4×	538 0.4×	938 2.0×	845 4.3×	223	3.9k
Meike Körner Switzerland	28	2.5k 1.2×	2.5k 1.3×	1.6k 1.2×	312 0.7×	428 2.2×	52	3.7k
Chae‐Yong Kim South Korea	33	1.1k 0.5×	392 0.2×	1.1k 0.8×	592 1.2×	517 2.7×	183	3.5k
Eyas M. Hattab United States	27	290 0.1×	198 0.1×	384 0.3×	408 0.9×	698 3.6×	91	2.3k
Michael Møller Denmark	34	230 0.1×	1.3k 0.7×	549 0.4×	292 0.6×	966 5.0×	161	4.2k
Bo Wängberg Sweden	39	2.2k 1.1×	1.6k 0.8×	1.5k 1.1×	1.1k 2.3×	357 1.8×	124	3.9k
Damian Wild Switzerland	36	2.9k 1.4×	2.6k 1.3×	1.5k 1.1×	607 1.3×	460 2.4×	127	4.6k

Countries citing papers authored by Frederico Costa

Since Specialization

Citations

This map shows the geographic impact of Frederico Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederico Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederico Costa more than expected).

Fields of papers citing papers by Frederico Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederico Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederico Costa. The network helps show where Frederico Costa may publish in the future.

Co-authorship network of co-authors of Frederico Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Frederico Costa. A scholar is included among the top collaborators of Frederico Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederico Costa. Frederico Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costa, Frederico, et al.. (2025). External low energy electromagnetic fields affect heart dynamics: surrogate for system synchronization, chaos control and cancer patient’s health. PubMed. 4. 1525135–1525135. 1 indexed citations

Costa, Frederico, Bertram Wiedenmann, Eckehard Schöll, & Jack A. Tuszyński. (2024). Emerging cancer therapies: targeting physiological networks and cellular bioelectrical differences with non-thermal systemic electromagnetic fields in the human body – a comprehensive review. SHILAP Revista de lepidopterología. 4. 1483401–1483401. 5 indexed citations

Pereira, Allan Andresson Lima, et al.. (2023). Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience. Cancers. 15(18). 4506–4506. 3 indexed citations

Costa, Frederico, Bertram Wiedenmann, Christoph Roderburg, Raphael Mohr, & Ghassan K. Abou‐Alfa. (2023). Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma. Cancer Medicine. 12(13). 13978–13990. 9 indexed citations

Costa, Frederico, et al.. (2022). The Effect of Physical Activity on Motor Skills of Children with Autism Spectrum Disorder: A Meta-Analysis. International Journal of Environmental Research and Public Health. 19(21). 14081–14081. 20 indexed citations

Hicks, Rodney J., Clarisse Dromain, Wouter W. de Herder, et al.. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology. 34(3). e13040–e13040. 13 indexed citations

Knebel, Franciele Hinterholz, Louise J. Barber, Alice Newey, et al.. (2020). Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers. 12(12). 3736–3736. 4 indexed citations

Lamarca, Ángela, Maxime Ronot, Salma Moalla, et al.. (2019). Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study. Clinical Cancer Research. 25(22). 6692–6699. 22 indexed citations

Ángel, Martín, Rui Weschenfelder, Frederico Costa, et al.. (2019). Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study. Journal of Clinical Medicine. 8(3). 405–405. 13 indexed citations

10.

Toumpanakis, Christos, Nicola Fazio, Eva Tiensuu Janson, et al.. (2018). Unmet Needs in Appendiceal Neuroendocrine Neoplasms. Neuroendocrinology. 108(1). 37–44. 22 indexed citations

11.

García‐Carbonero, Rocio, Anja Rinke, Juan W. Valle, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy. Neuroendocrinology. 105(3). 281–294. 82 indexed citations

12.

Pavel, Marianne, Juan W. Valle, Barbro Eriksson, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 105(3). 266–280. 110 indexed citations

13.

Braghiroli, Maria Ignez, João Evangelista Bezerra Neto, Rodrigo Ramella Munhoz, et al.. (2017). Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer. ecancermedicalscience. 11. 767–767. 11 indexed citations

14.

Fernandes, Gustavo dos Santos, et al.. (2016). P-154 Combined oxaliplatin, irinotecan and fluorouracil as a rescue regimen for heavily pretreated metastatic colorectal cancer patients. Annals of Oncology. 27. ii45–ii45.

15.

Pavel, Marianne, Dermot O’Toole, Frederico Costa, et al.. (2016). ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology. 103(2). 172–185. 738 indexed citations breakdown →

16.

Baselga, José, Frederico Costa, Henry Gómez, et al.. (2013). A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial. Trials. 14(1). 228–228. 31 indexed citations

17.

Costa, Frederico, et al.. (2013). Octreotide – A Review of its Use in Treating Neuroendocrine Tumours. European Oncology & Haematology. 9(2). 105–105. 10 indexed citations

18.

Costa, Frederico, et al.. (2012). Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours. Best Practice & Research Clinical Gastroenterology. 26(6). 843–854. 9 indexed citations

19.

Hoff, Paulo M., Everardo D. Saad, Frederico Costa, et al.. (2011). Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer. 11(2). 93–100. 63 indexed citations

20.

Barbault, Alexandre, et al.. (2009). Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. Journal of Experimental & Clinical Cancer Research. 28(1). 51–51. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact